Intracoronary autologous bone marrow stem cells transfer for patients with acute myocardial infarction: A meta-analysis of randomised controlled trials

International Journal of Cardiology

Volumn 136, Issue 2, 2009, Pages 178-185

  Zhang, Shu ning ^a   Sun, Ai jun ^a   Ge, Jun bo ^a   Yao, Kang ^a   Huang, Zhe yong ^a   Wang, Ke qiang ^a   Zou, Yun zeng ^a  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Acute myocardial infarction; Bone marrow stem cells; Meta analysis; Randomised controlled trials

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CLINICAL TRIAL; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE REMODELING; HUMAN; INCIDENCE; META ANALYSIS; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

BONE MARROW TRANSPLANTATION; HUMANS; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 67650718346     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.04.071     Document Type: Article

References (33)

1. Strauer B.E., Brehm M., Zeus T., et al. Repair of infracted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106 15 (2002) 1913-1918
2. Fernandez-Aviles F., San Roman J.A., Garci{dotless}a-Frade J., et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 7 95 (2004) 742-748
3. Kuethe F., Richartz B.M., Sayer H.G., et al. Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions. Int J Cardiol 97 1 (2004) 123-127
4. Mansour S., Vanderheyden M., De Bruyne B., et al. Intracoronary delivery of hematopoietic bone marrow stem cells and luminal loss of the infarct-related artery in patients with recent myocardial infarction. J Am Coll Cardiol 47 8 (2006) 1727-1730
5. Vulliet P.R., Greeley M., Halloran S.M., MacDonald K.A., and Kittleson M.D. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 363 9411 (2004) 783-784
6. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomised clinical trials: is blinding necessary?. Control Clin Trials 17 1 (1996) 1-12
7. Wollert K.C., Meyer G.P., Lotz J., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 9429 (2004) 141-148
8. Chen S.L., Fang W.W., Ye F., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94 1 (2004) 92-95
9. Ge J., Li Y., Qian J., et al. Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI). Heart 92 12 (2006) 1764-1767
10. Schachinger V., Erbs S., Elsasser A., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Eng J Med 355 12 (2006) 1210-1221
11. Janssens S., Dubois C., Bogaert J., et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367 9505 (2006) 113-122
12. Lunde K., Solheim S., Aakhus S., et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355 12 (2006) 1199-1209
13. Cohn J.N., Johnson G.R., Shabetai R., et al. Mechanistic data from the VA Cooperative Studies: ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. Circulation 87 Suppl 6 (1993) VI5-V6
14. Caplice N.M. The future of cell therapy for acute myocardial infarction. Nat Clin Pract Cardiovasc Med 3 Suppl 1 (2006) S129-S132
15. Bauersachs J., Thum T., Frantz S., and Ertl G. Cardiac regeneration by progenitor cells-bedside before bench?. Eur J Clin Invest 35 7 (2005) 417-420
16. Abdel-Latif A., Bolli R., Tleyjeh I.M., et al. Adult bone marrow-derived cells for cardiac repair. Arch Intern Med 167 10 (2007) 989-997
17. Zhang S., Ge J., Sun A., et al. Comparison of various kinds of bone marrow stem cells for the repair of infarcted myocardium: Single clonally purified non-hematopoietic mesenchymal stem cells serve as a superior source. J Cell Biochem 99 4 (2006) 1132-1147
18. Jyotsna M., Vemuganti G.K., Reddy P., and Chandra K.S. Autologous bone marrow-derived progenitor cell myocardial delivery for recent myocardial infarction patients following early angioplasty: results from a pilot study. Cardiovasc Revasc Med 7 4 (2006) 217-221
19. Schachinger V., Assmus B., Britten M.B., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44 8 (2004) 1690-1699
20. Meyer G.P., Wollert K.C., Lotz J., et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113 10 (2006) 1287-1294
21. Frigerio M., and Roubina E. Drugs for left ventricular remodeling in heart failure. Am J Cardiol 96 12A (2005) 10L-18L
22. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 4 (2001) 430-436
23. Mangi A.A., Noiseux N., Kong D., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9 9 (2003) 1195-1201
24. Kawamoto A., Gwon H.C., Iwaguro H., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103 5 (2001) 634-637
25. Schaefer A., Meyer G.P., Fuchs M., et al. Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial. Eur Heart J 27 8 (2006) 929-935
26. Fuchs S., Baffour R., Zhou Y.F., et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 37 6 (2001) 1726-1732
27. Zeng L., Hu Q., Wang X., et al. Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling. Circulation 115 14 (2007) 1866-1875
28. Thum T., Bauersachs J., Poole-Wilson P.A., Volk H.D., and Anker S.D. The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol 46 10 (2005) 1799-1802
29. Kang H.J., Kim H.S., Zhang S.Y., et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363 9411 (2004) 751-756
30. Bartunek J., Vanderheyden M., Vandekerckhove B., et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 112 Suppl 9 (2005) I178-183
31. Schachinger V., Erbs S., Elsasser A., et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 27 23 (2006) 2775-2783
32. Prabhakara S., Heggunje W., Harjai Gregg K.J., et al. Procedural success versus clinical risk 1status in determining discharge of patients after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 44 7 (2004) 1400-1407
33. Marenzi G., Moltrasio M., Assanelli E., et al. Impact of cardiac and renal dysfunction on inhospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty. Am Heart J 153 5 (2007) 755-762